The invention generally relates to refractive correction systems, and more particularly, to a technique for correcting refractive errors in multiple steps.
The field of ophthalmology for the past number of years has seen great strides in the development of refractive treatments intended to correct the vision of the eye. These techniques have evolved from the earlier radial keratotomy technique, in which slits in the cornea allowed the cornea to relax and reshape, to present techniques including photorefractive keratectomy (“PRK”), anterior lamellar keratectomy (“ALK”), laser in situ keratomileusis (“LASIK”), and thermal techniques such as laser thermal keratoplasty (“LTK”). All of these techniques strive to provide a relatively quick but lasting correction of vision.
At the same time, the diagnostic tools to determine what correction is needed have also advanced. A variety of new topography systems, pachemetry systems, wavefront sensors, and overall refractive error detection systems can detect not only the amounts of myopia, hyperopia, and astigmatism, but also, higher order aberrations of the eye, shapes and thickness of eye components and a host of diagnostic information for therapeutic use such as correcting or modifying the refractive properties of the eye; i.e., creating better vision. These diagnostic systems and techniques have the potential for permitting correction of both the fundamental and higher order defects, especially when used with even more refined refractive correction techniques, with the possibility that vision correction to better than 20/20 will someday be the norm.
A number of these higher order defects can be either induced by unsuccessful refractive treatment or can be inherent problems with the eye. For example, both radial keratotomy and laser refractive techniques can result in an asymmetric vision correction profile for a variety of reasons. Radial keratotomy can result in an over- or under-relaxation of one portion of the eye relative to the other, whereas laser techniques, especially if not properly centered, can result in a vision correction profile that is off of the optical or visual axis or some other axis of treatment. Advanced laser refractive techniques have in fact been used to subsequently correct for these off axis or otherwise asymmetric refractive errors. Moreover, photorefractive laser surgery for correction of myopia, hyperopia and/or astigmatism has been shown to induce higher order defects, both symmetrical such as spherical aberration and asymmetrical such as coma.
According to one feature of the invention, a technique is provided for correcting for asymmetric errors, i.e., defects that vary in magnitude about a defined reference axis, of the eyes in more than one step. First, one or more of a variety of diagnostic tools, such as, preferably a surface elevation-based topography system, or, alternatively a wavefront sensor, is employed to determine the refractive correction necessary to correct an off-axis (decentered) or otherwise asymmetric refractive error. Then, a treatment profile is calculated which does not necessarily fully correct vision, but rather converts, via partial correction; the off axis and/or asymmetric error into a relatively symmetric error. Then, the refractive error of the eye is again examined, and a follow-up treatment is performed to take the then partially corrected vision to fully corrected vision by correcting the residual symmetric defect.
Sometimes, when an asymmetric error is treated, the actual refractive results that do not necessarily match the predicted results. This can be for a variety of reasons. For example, an irregular thinning of the cornea can cause a reshaping of the cornea, which may be difficult to factor into calculations. This may depend upon the healing response, epithelial regrowth, etc. Further, ablation patterns are typically designed based upon a predicted amount of tissue removal per shot, but the actual ablation value can vary. Also, the refractive treatment can affect the tension in collagen fibers in the cornea causing reshaping. By first “pretreating” the eye to convert an asymmetric and/or off-axis error into a relatively on-axis and/or otherwise symmetric error, a more symmetric, and empirically verified treatment profile can then be applied to the eye. The follow-up treatment can occur within a very short period of time after the initial treatment, or can occur a matter of days or weeks later, as limited by physiological or other factors.
It will further be appreciated that the multistep treatment described herein is not limited merely to an asymmetric, then symmetric correction. Obviously, an initial step of “regularizing” a cornea must be followed up on the basis of any biodynamic response observed, which could require an asymmetric treatment also for the secondary treatment. Moreover, the multistep treatment comprises, in an embodiment of the invention, correcting lower order aberrations (Zernike 2nd order) with the primary treatment and higher order aberrations (3rd and higher Zernike order) with the secondary treatment. The general concept of the invention, therefore, is to provide a converging solution to the problem of refractive error correction such that subsequent responses to a treatment decrease which then requires a decreased subsequent treatment and so on.
The treatment steps are referred to as an initial, “centering” treatment and then a follow-up treatment preferably on a computer that calculates courses of treatment for a laser system.
Turning to
Referring to
Once this error profile 100 is developed, an initial treatment is developed in a step 106. Creating appropriate treatment profiles from error profiles is well known to the art. Generally, the initial treatment 106 is of a profile that will result in the eye's remaining refractive error being substantially symmetric and on-axis. It need not be perfectly so, because the purpose of the initial treatment is to ensure the subsequent treatment, discussed below, does not have gross volumetric asymmetries. But generally, the initial treatment 106 will be sufficient to remove gross asymmetries. Examples of the initial treatment 106 are discussed below in conjunction with
In any case, once this initial treatment 106 is derived the eye is treated, whether by LASIK, PRK, thermal techniques, or any of a variety of other techniques that have been or will be developed. This results in the eye having a new, intermediate refractive error profile 108, which is generally substantially symmetric about the approximate center 104 of the eye. The initial treatment 106 will necessarily have resulted in removal of more tissue on one portion of the eye then the other, as is illustrated in
Further, the profile 108 is generally symmetric, but may include higher order, but minor, errors to be corrected, for example, through laser profiling. Again, the point of the initial treatment 106 is to remove the majority of the tissue necessary to generally center and symmetrize the intermediate refractive profile 108. This reduces the effects of gross asymmetries in subsequent treatment; thus, the results of the subsequent treatment become more predictable.
After the initial treatment 106, with LASIK, preferably the flap would be replaced on the eye, which then is allowed to heal—a relatively short process. Alternatively, the eye can be immediately analyzed to determine the results of the LASIK treatment, perhaps adjusting the analysis based on known effects of edema, or swelling. Then, the eye is again refractively analyzed, again using one of a variety of techniques. At this stage of analysis, the same or a different refractive diagnostic tool can be used as is used in diagnosing the initial profile 100, and the tool can even be built into the laser treatment station.
A follow-up treatment 110 appropriate to correct the intermediate refractive error profile 108 is derived, and that treatment is then applied, yielding a final profile 112, preferably the perfect profile for perfect refractive correction of the eye, yielding emmetropia. This is centered at the eye's center 104, and although a slight topography is shown, preferably this topography is the topography necessary to yield perfect vision correction.
Turning to
As discussed in conjunction with
Rather than defining the desired intermediate refractive profile 108 in terms of surface topography, the goal can be to achieve a cornea with a symmetric corneal thickness. For example, it may be desired to make the initial treatment 106 such that the cornea thickness is essentially the same at a predetermined distance from the center of the cornea. This forms a regular cornea thickness rather than a regular anterior surface profile (although the two will typically be similar). But starting from this regular cornea thickness, the eye can then be treated to refractively correct the remainder of the errors and the follow-up treatment 110.
Illustrating the typical steps that would be applied,
When an eye requires an irregular treatment profile, the desired result is a symmetric refractive profile, but the very fact that the treatment profile applied is irregular can induce irregularities in the resulting refractive profile of the eye. For example, the thinning of one portion of eye relative to the other can induce its own refractive effects. Thus, the follow-up treatment 110 will generally correct not only myopia or hyperopia, and certain higher order effects, but will also correct for any unpredicted refractive error induced by the initial treatment 106. In any case, the follow-up treatment 110 will typically be far less asymmetric then the initial treatment 106, thus only minimally inducing additional asymmetric refractive error. It is further possible to perform the process in more than two steps, having a further follow-up treatment for slight decentration that may result. This may be indicated for particularly gross asymmetries.
There are other reasons for attempting to create a regular refractive error profile in the initial treatment 106 to be corrected in the follow-up treatment 110. While an excimer laser, for example, can very precisely remove tissue from the cornea, the actual treatment profile necessary to correct for different degrees of myopia, hyperopia, and astigmatism have been found to require adjustment based on empirical results. These adjustments can depend on many factors, such as the amount of correction, and whether a treatment is an initial treatment or a subsequently performed treatment.
Thus the general embodiment of the invention is to obtain a diagnostic measurement of the patient's eye and to make a first-stage treatment preferably to remove or correct gross defects. The eye's response to the surgical trauma, which may comprise merely the flap cut of a LASIK procedure, is observed. Based upon the observation of the biodynamic response, a second-stage of the multi-stage treatment is performed. Again, the biodynamic response is observed and treatment is continued as appropriate or is considered complete. The preferable outcome is a converging solution embodied by a progressively smaller response and/or more complete correction after each treatment stage.
The empirical results of a number of standard types of treatments generally become established over a large number of treatments. For example, in certain circumstances and conditions one may find an ablation rate in corneal tissue of 0.35 microns removed by a 120 mjoule per square centimeter per shot (a variety of rates are possible, however). If one were to assume such an ablation rate, one would typically find that ablation on a PMMA plate with the theoretically calculated profile would yield the theoretically predicted amount of correction for both myopia and hyperopia. In practice on an actual cornea, however, a single, fixed ablation rate may not yield the result predicted based on a uniform ablation rate; instead, the amount of ablation necessary is typically dependent on whether myopia or hyperopia is to be treated, and the amount of treatment. For example, to treat for −6.00 diopters of myopia, instead of assuming the ablation rate of 0.35, one might use a theoretical ablation rate of 0.46 to calculate the treatment profile. Thus, the treatment profile desired would be a standard treatment profile for −6.00 diopters of myopia, but multiplied by 0.35/0.46. Therefore, the actual treatment profile employed would be the equivalent of theoretical treatment for approximately −4.50 diopters of myopia. Put another way, less ablation is needed than is theoretically predicted. On the other hand, to treat for hyperopia, such as +6.00 diopters of hyperopia, an ablation rate of 0.25 microns per shot can be used in the calculation, and thus to treat for hyperopia of +6.00 diopters, one would actually apply an ablation profile that would theoretical yield the result of +8.40 diopters assuming a constant ablation rate. Alternatively, one could assume a fixed ablation rate but instead scale the desired treatment. That is, one could scale down the treatment to be calculated for myopia from −6.000 to −4.50, and scale up the treatment to be calculated for hyperopia from +6.00 to +8.40. Similarly, the amount of under/overtreatment necessary could be quantified as a percentage. For example, it could be empirically determined that for myopia within a particular range, the actual treatment should only be 75% of the otherwise calculated treatment; for hyperopia, perhaps, a 135% scaling factor is appropriate. The point of all this is not a specific empirical treatments that are developed and how they differ from simplified theoretical calculations based on constant ablation rates, but rather the fact that such empirically developed treatments often yield better results than treatments based purely on theory. By placing the eye in a condition for which many previous treatments have been performed—such as myopia or hyperopia with varying amounts of astigmatism—that empirical data and experience can be brought into play.
There are a variety of reasons that the empirical data diverges from the theoretically predicted outcomes. The cornea tissue is made up of collagen fibers, which are under tension. When the ablation “cuts” those fibers, it could allow additional water to be absorbed into the collagen, effecting the resulting ablation profile. The result could also be influenced by the thinning of the cornea, and the resulting “bulging” of the treated cornea. Also, the deviation of actual treatments from theoretical results is important in subsequent ablation treatments. It has been seen that when performing a follow-up ablation on a cornea, far less actual ablation is necessary than would be predicted to achieve a desired result. Therefore, only a portion of the predicted ablation is needed. Typically, this would range somewhere between 40 to 80% of the theoretically predicted amount of ablation needed, and preferably around 60% of the theoretically required ablation.
As additional empirical data is gathered, it can yield ever more precise results and take into account additional variables. For example, the thickness of the cornea, whether the treatment is a “retreatment”, and other variables could eventually be factored into the empirically developed treatment. Further, empirical data may further provide courses of treatment not only for myopia, hyperopia, and astigmatism, but also for higher order errors. But again, by achieving a known “starting point”, that data can be brought to bear.
The overall effect of these differences between the theoretical outcomes and the empirical outcomes is that it is preferable in a two step treatment to employ the initial treatment 106 to yield a resulting refractive error profile 108 for which empirical data is available. Thus, if the initial treatment 106 yields a refractive error profile 108 that, for example, simply requires −2.00 diopters of myopic correction with −1.00 diopter of astigmatism, generally such refractive treatments will have historical, empirical data from which surgeons can draw, thus appropriately adjusting any theoretical ablation profile to yield the actual desired result.
In this approach of
In sum, while even symmetric treatments for conditions such as myopia, hyperopia, and astigmatism typically yield refractive end results that differ from the predicted result, these differences are predictable based on empirical data. That is, based on corneal thickness, surface profiles, previous treatments, and other parameters, doctors can predict how much to “adjust” the actual course of refractive treatments to yield the optimal end result. So employing techniques according to the invention, as illustrated in
Turning to
Generally, the computer system C runs the software which develops a course of treatment based on parameters provided by the physician as well as data from the topography system T. It can employ a variety of algorithms, generally depending on the type of excimer laser system E. If the excimer laser system E employs a relatively large fixed spot size, for example, algorithms described in PCT Application Serial No. PCT/EP95/04028 can be used to develop a course of treatment based on an initial refractive profile and a desired refractive profile. Of course, a variety of laser systems and algorithms provide for treatment of irregular refractive errors, and software suitable for a particular laser system should be employed to develop the refractive profiles as illustrated in
As will be appreciated, the technique can employ a variety of systems, such as an excimer laser system, a thermal system, radial keratotomy, or related systems, and employ a variety of diagnostic tools, such as a surface topography analysis system, a wavefront analysis system and the like.
The foregoing disclosure and description of the preferred embodiment are illustrative and explanatory thereof, and various changes in the components, circuit elements, circuit configurations, and signal connections, as well as in the details of the illustrated circuitry and construction and method of operation may be made without departing from the spirit and scope of the invention.
Number | Date | Country | Kind |
---|---|---|---|
19950789.9 | Oct 1999 | DE | national |
10014481.0 | Mar 2000 | DE | national |
This application is a continuation of, and claims priority to, parent application U.S. Ser. No. 10/110,891 entitled Method and Apparatus for Multi-Step Correction of Ophthalmic Refractive Errors filed on Dec. 23, 2002, and to PCT Application Number PCT/EP00/10377 filed on Apr. 26, 2001, German National Application Number 10014481.0 filed on Mar. 23, 2000, and German National Application Number 19950789.9 filed on Oct. 21, 1999, the subject matters of which are incorporated by reference herein in their entireties.
Number | Date | Country | |
---|---|---|---|
Parent | 10110891 | Dec 2002 | US |
Child | 12109801 | US |